Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05593107
NA

68Ga-N188 PET/CT Imaging in Malignancy

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

The Nectin-4 protein belongs to the cell adhesion factors family and has a tissue-specific expression spectrum in normal human tissues. However, Nectin-4 is overexpressed in various malignancies, especially those of epithelial origins, such as uroepithelial carcinoma, making Nectin-4 a highly specific and significant imaging target for malignancies. \[68Ga\]N188, a novel molecular probe of PET imaging agent that targets Nectin-4, can be used in the diagnosis and research of a wide variety of Nectin-4 high-expression malignancies, including bladder cancer.

Official title: A Study to Evaluate 68Ga-N188 PET/CT Imaging of Nectin-4 Expression in Malignant Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

203

Start Date

2022-08-12

Completion Date

2025-07-31

Last Updated

2024-11-21

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

[68Ga]N188

68Ga-N188 is injected intravenously with a dose of 0.06-0.08 mCi/kg.

Locations (1)

Peking University First Hospital

Beijing, Beijing Municipality, China